A cross-sectional international study found that women with autoimmune disease are more likely to have longer delays to diagnosis and to have misdiagnoses.

An observational study suggests benefit from glucagon-like peptide-1 receptor agonist (GLP-1 RA) use in end-stage kidney disease (ESKD).

Profound advances in breast cancer testing have been made since testing first began in 1996. (HealthDay News) — Women who had genetic testing for inherited cancer risk years ago may want to ask about ...

A study showed that certain pregnancy complications are associated with an increased risk for cardiometabolic-renal conditions in subsequent years.

A meta-analysis of randomized trials supports intensive blood pressure lowering in chronic kidney disease (CKD) not on dialysis.

Patients with intermediate-risk prostate cancer who can safely forgo androgen deprivation therapy (ADT) may be spared its quality-of-life effects.

Two multinational cross-sectional studies revealed nail disorders and hair and scalp changes occur frequently among GLP-1 RA users.

Study showed that the rates of sustained tobacco abstinence are higher with financial incentives vs usual care.

A study showed that personalized support significantly increases likelihood that first-degree relatives of patients with hereditary cancers complete genetic testing.